Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal JMGCB Journal of Medical Genetics and Clinical Biology (JMGCB)
D.A , Urunbayeva
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Nursing

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
DIABETES MELLITUS AND COVID-19. CARDIOVASCULAR COMPLICATIONS AND COURSE OF TYPE 2 DIABETES MELLITUS AFTER CORONAVIRUS INFECTION D.K, Najmutdinova; D.A , Urunbayeva; N.G, Sadikova; S.A, Pulotova
Journal of Medical Genetics and Clinical Biology Vol. 1 No. 9 (2024): Journal of Medical Genetics and Clinical Biology
Publisher : PT ANTIS INTERNATIONAL PUBLISHER

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v1i9.906

Abstract

The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has had profound effects on global health and economics since its emergence in late 2019. Over 770 million confirmed cases of COVID-19 have been reported worldwide, with millions of deaths attributed to the virus. Studies have shown that individuals with T2DM are at a higher risk of severe illness and mortality if they contract COVID-19. The presence of diabetes, especially when poorly controlled, can exacerbate the inflammatory response to the virus. Patients with T2DM often have comorbidities such as cardiovascular disease, hypertension, and obesity, which further increase the risk of severe COVID-19 complications
DIABETES MELLITUS AND COVID-19. CARDIOVASCULAR COMPLICATIONS AND COURSE OF TYPE 2 DIABETES MELLITUS AFTER CORONAVIRUS INFECTION D.K, Najmutdinova; D.A , Urunbayeva; N.G, Sadikova; S.A, Pulotova
Journal of Medical Genetics and Clinical Biology Vol. 1 No. 9 (2024): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v1i9.906

Abstract

The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has had profound effects on global health and economics since its emergence in late 2019. Over 770 million confirmed cases of COVID-19 have been reported worldwide, with millions of deaths attributed to the virus. Studies have shown that individuals with T2DM are at a higher risk of severe illness and mortality if they contract COVID-19. The presence of diabetes, especially when poorly controlled, can exacerbate the inflammatory response to the virus. Patients with T2DM often have comorbidities such as cardiovascular disease, hypertension, and obesity, which further increase the risk of severe COVID-19 complications
Co-Authors D.K, Najmutdinova N.G, Sadikova S.A, Pulotova